Otávio Augusto Chaves, Carolina Q. Sacramento, André C. Ferreira, Mayara Mattos, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, . . . Thiago Moreno L. Souza. (2021). Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M<sup>pro</sup>, Impairing Variants Replication In Vitro and In Vivo. MDPI AG.
Chicago Style (17th ed.) CitationOtávio Augusto Chaves, et al. Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M<sup>pro</sup>, Impairing Variants Replication In Vitro and In Vivo. MDPI AG, 2021.
MLA (9th ed.) CitationOtávio Augusto Chaves, et al. Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M<sup>pro</sup>, Impairing Variants Replication In Vitro and In Vivo. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.